DCF — MELROSEWAKEFIELD HEALTHCARE INC
Enterprise Value: $-192.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-192.4M
Enterprise Value
$-64.3M
PV of Cash Flows
$-128.0M
PV of Terminal Value
$-206.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $224.0M | $-10.1M | -5.0% | $-19.6M | $-17.8M |
| Year 2 | $230.7M | $-8.1M | -4.0% | $-17.8M | $-14.7M |
| Year 3 | $237.7M | $-5.9M | -3.0% | $-16.0M | $-12.0M |
| Year 4 | $244.8M | $-4.9M | -2.0% | $-15.3M | $-10.4M |
| Year 5 | $252.1M | $-4.4M | -2.0% | $-15.1M | $-9.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-192.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$217.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05000000022988601
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5